Article

Epigenetic genes alterations in metastatic solid tumors: results from the prospective precision medicine MOSCATO and MATCH-R trials

2022-04-20

Abstract excerpt

<h4>Purpose: </h4> Although the role of epigenetic alterations in oncogenesis has been well studied, their prevalence in metastatic solid tumors is still poorly described. We therefore aimed at: (i) describing the presence of epigenetic gene alterations (EGA) - defined by an alteration in a gene encoding an epigenetic regulator; and (ii) evaluating their relationship with clinical characteristics and outcome in pa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ff628f78-f99d-5daf-a770-919448ffc1b5
DOI: 10.21203/rs.3.rs-1553387/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epigenetic genes alterations in metastatic solid tumors: results from the prospective precision medicine MOSCATO and MATCH-R trialsDOI 10.21203/rs.3.rs-1553387/v1Read

Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.Semantic proximity Read

Pragmatic Nationwide Master Observational Trial Based on Genomic Alterations in Advanced Solid Tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II Study Protocol KCSG AL-22-09Semantic proximity Read

Comprehensive genomic profiling of over 10,000 advanced solid tumors.Semantic proximity Read

Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.Semantic proximity Read

Genomic Divergence Between Matched Primary and Metastatic Tumors Across Cancer Types: A Pan-Cancer Analysis of 5,692 SamplesSemantic proximity Read

Pan-cancer whole genome analyses of metastatic solid tumorsSemantic proximity Read

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersSemantic proximity Read

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.Semantic proximity Read

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.Semantic proximity Read

Targetable Alterations in Adult Patients With Soft-Tissue SarcomasSemantic proximity Read

Next-Generation Sequencing-Based Evaluation of the Actionable Mutational Landscape in Solid Tumors: the “MOZART” Prospective Observational StudySemantic proximity Read

Implementation and use of whole exome sequencing for metastatic solid cancer.Semantic proximity Read